Aull & Monroe Investment Management Corp Abb Vie Inc. Transaction History

Aull & Monroe Investment Management Corp

$202 Million
Q2 2024

A detailed history of Aull & Monroe Investment Management Corp transactions in Abb Vie Inc. stock. As of the latest transaction made, Aull & Monroe Investment Management Corp holds 19,653 shares of ABBV stock, worth $3.83 Million. This represents 1.67% of its overall portfolio holdings.

Number of Shares

19,653

Previous 21,935 10.4%

Holding current value

$3.83 Million

Previous $3.99 Million 15.62%

% of portfolio

1.67%

Previous 1.84%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 19, 2024	SELL	$154.79 - $180.76 $353,230 - $412,494	-2,282 Reduced 10.4%	19,653 $3.37 Million
Q1 2024 May 06, 2024	SELL	$159.82 - $182.1 $69,521 - $79,213	-435 Reduced 1.94%	21,935 $3.99 Million
Q4 2023 Jan 25, 2024	SELL	$137.6 - $154.97 $50,912 - $57,338	-370 Reduced 1.63%	22,370 $3.47 Million
Q3 2023 Nov 13, 2023	SELL	$133.59 - $154.65 $26,718 - $30,930	-200 Reduced 0.87%	22,740 $3.39 Million
Q1 2023 May 12, 2023	BUY	$144.61 - $166.54 $12,147 - $13,989	84 Added 0.37%	22,940 $3.66 Million
Q4 2022 Feb 07, 2023	SELL	$138.31 - $165.87 $84,922 - $101,844	-614 Reduced 2.62%	22,856 $3.7 Million
Q1 2022 May 02, 2022	SELL	$131.98 - $163.75 $3,299 - $4,093	-25 Reduced 0.11%	23,470 $3.81 Million
Q4 2021 Feb 02, 2022	SELL	$107.43 - $135.93 $22,990 - $29,089	-214 Reduced 0.9%	23,495 $3.18 Million
Q3 2021 Oct 26, 2021	BUY	$106.4 - $120.78 $5,320 - $6,039	50 Added 0.21%	23,709 $2.56 Million
Q1 2021 Apr 19, 2021	BUY	$102.3 - $112.62 $50,740 - $55,859	496 Added 2.14%	23,659 $2.56 Million
Q4 2020 Feb 02, 2021	SELL	$80.49 - $108.67 $9,739 - $13,149	-121 Reduced 0.52%	23,163 $2.48 Million
Q3 2020 Nov 02, 2020	BUY	$85.91 - $100.83 $120,274 - $141,162	1,400 Added 6.4%	23,284 $2.04 Million
Q2 2020 Jul 28, 2020	SELL	$73.37 - $98.18 $141,237 - $188,996	-1,925 Reduced 8.09%	21,884 $2.15 Million
Q1 2020 Apr 22, 2020	SELL	$64.5 - $97.79 $4,837 - $7,334	-75 Reduced 0.31%	23,809 $1.81 Million
Q4 2019 Feb 04, 2020	SELL	$72.13 - $90.25 $39,671 - $49,637	-550 Reduced 2.25%	23,884 $2.12 Million
Q3 2019 Oct 30, 2019	SELL	$62.98 - $75.72 $74,946 - $90,106	-1,190 Reduced 4.64%	24,434 $1.85 Million
Q2 2019 Jul 29, 2019	SELL	$65.7 - $83.98 $19,710 - $25,194	-300 Reduced 1.16%	25,624 $1.86 Million
Q1 2019 Apr 18, 2019	SELL	$77.14 - $90.79 $80,997 - $95,329	-1,050 Reduced 3.89%	25,924 $2.09 Million
Q4 2018 Feb 13, 2019	SELL	$77.85 - $96.01 $105,097 - $129,613	-1,350 Reduced 4.77%	26,974 $2.49 Million
Q3 2018 Oct 31, 2018	SELL	$88.91 - $98.84 $35,564 - $39,536	-400 Reduced 1.39%	28,324 $2.68 Million
Q2 2018 Jul 24, 2018	SELL	$89.78 - $106.23 $26,934 - $31,869	-300 Reduced 1.03%	28,724 $2.66 Million
Q1 2018 May 10, 2018	SELL	$92.01 - $123.21 $9,201 - $12,321	-100 Reduced 0.34%	29,024 $2.75 Million
Q4 2017 Jan 29, 2018	SELL	$89.56 - $98.21 $60,900 - $66,782	-680 Reduced 2.28%	29,124 $2.82 Million
Q2 2017 Aug 14, 2017	BUY	N/A	29,804	29,804 $2.16 Million

Others Institutions Holding ABBV

# of Institutions

3,694

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $344B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aull & Monroe Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Aull & Monroe Investment Management Corp with notifications on news.

Account

Aull & Monroe Investment Management Corp Abb Vie Inc. Transaction History